Victory Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.1K | Sell |
11,897
-32
| -0.3% | -$78 | ﹤0.01% | 2419 |
|
|
2025
Q1 | $79.6K | Buy |
11,929
+1,658
| +16% | +$11.1K | ﹤0.01% | 2334 |
|
|
2024
Q4 | $129K | Sell |
10,271
-366
| -3% | -$4.6K | ﹤0.01% | 2305 |
|
|
2024
Q3 | $196K | Sell |
10,637
-171
| -2% | -$3.16K | ﹤0.01% | 2230 |
|
|
2024
Q2 | $233K | Sell |
10,808
-37,210
| -77% | -$801K | ﹤0.01% | 2163 |
|
|
2024
Q1 | $1.29M | Buy |
48,018
+2,510
| +6% | +$67.6K | ﹤0.01% | 1615 |
|
|
2023
Q4 | $1.36M | Buy |
45,508
+6,298
| +16% | +$189K | ﹤0.01% | 1576 |
|
|
2023
Q3 | $803K | Sell |
39,210
-6,850
| -15% | -$140K | ﹤0.01% | 1762 |
|
|
2023
Q2 | $915K | Buy |
46,060
+6,410
| +16% | +$127K | ﹤0.01% | 1718 |
|
|
2023
Q1 | $679K | Buy |
+39,650
| New | +$679K | ﹤0.01% | 1881 |
|
|
2021
Q4 | – | Sell |
-9,066
| Closed | -$271K | – | 2833 |
|
|
2021
Q3 | $271K | Sell |
9,066
-324
| -3% | -$9.69K | ﹤0.01% | 2418 |
|
|
2021
Q2 | $416K | Buy |
9,390
+457
| +5% | +$20.2K | ﹤0.01% | 2294 |
|
|
2021
Q1 | $396K | Buy |
8,933
+883
| +11% | +$39.1K | ﹤0.01% | 2305 |
|
|
2020
Q4 | $441K | Buy |
+8,050
| New | +$441K | ﹤0.01% | 2144 |
|
|
2020
Q2 | – | Sell |
-16,476
| Closed | -$230K | – | 3108 |
|
|
2020
Q1 | $230K | Buy |
16,476
+5,654
| +52% | +$78.9K | ﹤0.01% | 2299 |
|
|
2019
Q4 | $246K | Buy |
10,822
+2,944
| +37% | +$66.9K | ﹤0.01% | 2260 |
|
|
2019
Q3 | $92K | Buy |
+7,878
| New | +$92K | ﹤0.01% | 2464 |
|